Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function-Reference-Cited by-同舟云学术

Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function

Published:2014-02-11 Issue:5 Volume:37 Page:745-752
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Bartlett David C.,Lloyd Carla,McKiernan Patrick J.,Newsome Phil N.

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10545-014-9683-x

Reference24 articles.

1. al-Dhalimy M, Overturf K, Finegold M, Grompe M (2002) Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Mol Genet Metab 75:38–45

2. Arnon R, Annunziato R, Miloh T et al (2011) Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database. Pediatr Transplant 15:400–405

3. Arora-Gupta N, Davies P, McKiernan P, Kelly DA (2004) The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 8:145–150

4. Bartlett DC, Preece MA, Holme E, Lloyd C, Newsome PN, Mckiernan PJ (2013) Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1. J Inherit Metab Dis 36:15–20

5. Baumann U, Duhme V, Auth MK, McKiernan PJ, Holme E (2006) Lectin-reactive alpha-Fetoprotein in patients with tyrosinemia Type I and hepatocellular carcinoma. J Pediatr Gastroenterol Nutr 43:77–82

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation spectrum of Tyrosinemia type I in Iran, A retrospective cohort study;European Journal of Medical Genetics;2024-10

2. Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites - A Review;Current Drug Safety;2024-05

3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01

5. Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children;Clinical Medicine Insights: Pediatrics;2024-01